Asociación entre el uso de cigarrillos electrónicos y la enfermedad pulmonar obstructiva crónica

Bryan Anthony Urbina Salazar, Washington David Arias Calvache

Resumen


Actualmente, los cigarrillos electrónicos se comercializan de manera de libre como un sustituto menos dañino a los cigarrillos ordinarios, sin embargo, la asociación entre el uso de estos y la enfermedad pulmonar obstructiva crónica (EPOC) no ha sido estudiada a fondo, la toxicidad pulmonar es la más frecuente, dado que el pulmón es el sitio principal de exposición a los aerosoles como los cigarrillos electrónicos.


La EPOC es una de las primeras causas de morbilidad y mortalidad a nivel mundial, en este documento se describe la relación que existe entre el uso de los cigarrillos y la presencia de la enfermedad entre otros factores. Estudios in vitro e in vivo en animales han demostrado que la exposición a los cigarrillos electrónicos desencadena una respuesta inflamatoria similar a la que se observa con el humo del cigarrillo convencional, provocando la aparición de enfermedades respiratorias crónicas, como el asma y la EPOC.


Palabras clave


EPOC; cigarrillos electrónicos; trombo; mesenterio; angiografía; revascularización.

Texto completo:

PDF HTML XML

Referencias


Jerzyński T, Stimson G V, Shapiro H, Król G. Estimation of the global number of e-cigarette users in 2020. Harm Reduct J. (2021) 18:1–10. 10.1186/s12954-021-00556-7

Osei AD, Mirbolouk M, Orimoloye OA, Dzaye O, Uddin SMI, Benjamin EJ, et al. Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017. American Journal of Preventive Medicine. 2020 Mar 1;58(3):336–42.

Wills TA, Pagano I, Williams RJ, Tam EK. E-cigarette use and respiratory disorder in an adult sample. Drug and Alcohol Dependence. 2019 Jan 1;194:363–70.

Bhatta DN, Glantz SA. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. American Journal of Preventive Medicine. 2020 Feb 1;58(2):182–90.

Wills TA, Soneji SS, Choi K, Jaspers I, Tam EK. E-cigarette use and respiratory disorders: An integrative review of converging evidence from epidemiological and laboratory studies. European Respiratory Journal. 2021 Jan 1;57(1).

Agustí A, Hogg JC. Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 2019 Sep 26;381(13):1248–56.

Higham A, Bostock D, Booth G, Dungwa J v., Singh D. The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses. International Journal of COPD. 2018 Mar 23;13:989–1000.

Celli BR, Wedzicha JA. Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 2019 Sep 26;381(13):1257–66

Galstyan E, Galimov A, Sussman S. Comentario: El surgimiento de los mods Pod en las tiendas de vaporizador. Eval Salud Prof 2019; 42 :118-24. 10.1177/0163278718812976

Pearson JL, Reed DM, Villanti AC. Vapes, e-cigs y mods: ¿cómo llaman los adultos jóvenes a los cigarrillos electrónicos? Nicotine Tob Res 2018. 10.1093/ntr/nty223

Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019 Sep 30;366:l5275. doi: 10.1136/bmj.l5275.

Reinikovaite V, Rodriguez IE, Karoor V, et al. The effects of electronic cigarette vapour on the lung: direct comparison to tobacco smoke. Eur Respir J. 2018;51(4):1701661 10.1183/13993003.01661-2017.

Crotty Alexander LE, Drummond CA, Hepokoski M, et al. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol. 2018;314(6):R834‒R847. 10.1152/ajpregu.00270.2017.

Polosa R, Morjaria JB, Prosperini U, Busà B, Pennisi A, Malerba M, et al. COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up. Therapeutic Advances in Chronic Disease. 2020;11

Darcy McAlinden K, Suji Eapen M, Wenying Lu X, Pawan Sharma X, Singh Sohal S. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease. Am J Physiol Lung Cell Mol Physiol [Internet]. 2020;319:585–95. Available from: www.ajplung.org

Martin EM, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2016;311(1):L135‒L144. 10.1152/ajplung.00170.2016

Stratton K, Kwan LY, Eaton DL, Eds., 2018. Public health consequences of e-cigarettes: A consensus study report of the National Academies of Science, Engineering, and Medicine Washington, DC: National Academies Press.

Ghosh A, Coakley RC, Mascenik T, et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med. 2018;198(1):67‒76. 10.1164/rccm.201710-2033oc

Bagale K, Kulkarni R. A Systematic Review of the Literature Examining the Effects of Cigarette Smoke and e-Cigarette Vapor on the Virulence of Human Pathogenic Bacteria. Int J Environ Res Public Health. 2022 Sep 30;19(19):12518. doi: 10.3390/ijerph191912518. PMID: 36231813; PMCID: PMC9565164.

Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model. Journal of Cardiovascular Pharmacology and Therapeutics. 2023;28. doi:10.1177/10742484231155992

Dai W, Shi J, Siddarth P, et al. Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model. Journal of Cardiovascular Pharmacology and Therapeutics. 2023;28. doi:10.1177/10742484231155992

Wasfi RA, Bang F, de Groh M, Champagne A, Han A, Lang JJ, McFaull SR, Melvin A, Pipe AL, Saxena S, Thompson W, Warner E, Prince SA. Chronic health effects associated with electronic cigarette use: A systematic review. Front Public Health. 2022 Oct 6;10:959622. doi: 10.3389/fpubh.2022.959622. PMID: 36276349; PMCID: PMC9584749.

Perrine CG, Pickens CM, Boehmer TK, King BA, Jones CM, DeSisto CL, et al.. Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping - United States, 2019. MMWRMorbidity Mortal Wkly Rep. (2019) 68:860–4. 10.15585/mmwr.mm6839e1

Podzolkov VI, Bragina AE, Druzhinina NA, Vasil'eva LV, Osadchiy KK, Dubchak AE, et al.. Relation between tobacco smoking/electronic smoking and albuminuria/vascular stiffness in young people without cardiovascular diseases. Kidney Blood Press Res. (2020) 45:467–76. 10.1159/000507510

Haziza C, Bourdonnaye de La, Donelli A, Skiada D, Poux V, Weitkunat R, et al.. Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol tobacco heating system 2.2 for three months (Part 2). Nicotine Tob Res. (2020) 22:549–59. 10.1093/ntr/ntz084

Arastoo S, Haptonstall KP, Choroomi Y, Moheimani R, Nguyen K, Tran E, et al.. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents. Am J Physiol - Hear Circ Physiol. (2020) 319:H262–70. 10.1152/ajpheart.00192.2020

Fetterman JL, Keith RJ, Palmisano JN, McGlasson KL, Weisbrod RM, Majid S, et al.. Alterations in vascular function associated with the use of combustible and electronic cigarettes. J Am Heart Assoc. (2020) 9:e014570. 10.1161/JAHA.119.014570

Haptonstall KP, Choroomi Y, Moheimani R, Nguyen K, Tran E, Lakhani K, et al.. Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people. Am J Physiol Heart Circ Physiol. (2020) 319:H547–56. 10.1152/ajpheart.00307.2020

Ip M, Diamantakos E, Haptonstall K, Choroomi Y, Moheimani RS, Nguyen KH, et al.. Tobacco and electronic cigarettes adversely impact ECG indexes of ventricular repolarization: implication for sudden death risk. Am J Physiol Circ Physiol. (2020) 318:H1176–84. 10.1152/ajpheart.00738.2019

Sakaguchi C, Nagata Y, Kikuchi A, Takeshige Y, Minami N. Differences in levels of biomarkers of potential harm among users of a heat-not-burn tobacco product, cigarette smokers, and never-smokers in Japan: a post-marketing observational study. Nicotine Tob Res. (2021) 23:1143–52. 10.1093/ntr/ntab014

erez MF, Atuegwu NC, Mortensen EM, Oncken C. The inflammatory biomarker YKL-40 is elevated in the serum, but not the sputum, of e-cigarette users. Exp Lung Res. (2021) 47:55–66. 10.1080/01902148.2020.1847216

Haziza C, Bourdonnaye de La, Donelli A, Skiada D, Poux V, Weitkunat R, et al.. Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol tobacco heating system 2.2 for three months (Part 2). Nicotine Tob Res. (2020) 22:549–59. 10.1093/ntr/ntz084

Ludicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, et al.. Effects of switching to the menthol tobacco heating system 22, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settin. Nicotine Tob Res. (2018) 20:173–82. 10.1093/ntr/ntx028

Sakaguchi C, Nagata Y, Kikuchi A, Takeshige Y, Minami N. Differences in levels of biomarkers of potential harm among users of a heat-not-burn tobacco product, cigarette smokers, and never-smokers in Japan: a post-marketing observational study. Nicotine Tob Res. (2021) 23:1143–52. 10.1093/ntr/ntab014

Sakaguchi C, Nagata Y, Kikuchi A, Takeshige Y, Minami N. Differences in levels of biomarkers of potential harm among users of a heat-not-burn tobacco product, cigarette smokers, and never-smokers in Japan: a post-marketing observational study. Nicotine Tob Res. (2021) 23:1143–52. 10.1093/ntr/ntab014

Kizhakke Puliyakote AS, Elliott AR, Sa RC, Anderson KM, Crotty Alexander LE, Hopkins SR. Vaping disrupts ventilation-perfusion matching in asymptomatic users. J Appl Physiol. (2021) 130):308–17. 10.1152/japplphysiol.00709.2020

Meo SA, Ansary MA, Barayan FR, Almusallam AS, Almehaid AM, Alarifi NS, et al.. Electronic cigarettes: impact on lung function and fractional exhaled nitric oxide among healthy adults. Am J Mens Health. (2019) 13:1557988318806073. 10.1177/1557988318806073

Pulvers K, Nollen NL, Rice M, Schmid CH, Qu K, Benowitz NL, et al.. Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among african american and latinx smokers: a randomized clinical trial. JAMA Netw Open. (2020) 3:26324. 10.1001/jamanetworkopen.2020.26324

Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis . 1989;140:S3–S8

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, et al. It is time for the world to take COPD seriously: a statement from the GOLD board of directors. Eur Respir J . 2019;54:1900914

Ragland MF, Benway CJ, Lutz SM, Bowler RP, Hecker J, Hokanson JE, et al. genetic advances in chronic obstructive pulmonary disease: insights from COPDGene. Am J Respir Crit Care Med . 2019;200:677–690.

Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. Después del asma: redefiniendo las enfermedades de las vías respiratorias. lanceta _ 2018; 391 :350–400.

Agustí A, Hogg JC. Update on the pathogenesis of COPD: reply. N Engl J Med . 2019;381:2484

Divo MJ, Celli BR, Poblador-Plou B, Calderón-Larrañaga A, de-Torres JP, Gimeno-Feliu LA, et al.EpiChron—BODE Collaborative Group Chronic obstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron cohort. PLoS One . 2018;13:e0193143.

Perez TA, Castillo EG, Ancochea J, Pastor Sanz MT, Almagro P, Martínez-Camblor P, et al. Sex differences between women and men with COPD: a new analysis of the 3CIA study. Respir Med . 2020;171:106105

Hansel NN, Putcha N, Woo H, Peng R, Diette GB, Fawzy A, et al. Randomized clinical trial of air cleaners to improve indoor air quality and chronic obstructive pulmonary disease health: results of the CLEAN AIR study. Am J Respir Crit Care Med . 2022;205:421–430.

Baraldi E, Bonadies L, Manzoni P. Evidence on the link between respiratory syncytial virus infection in early life and chronic obstructive lung diseases. Am J Perinatol . 2020;37:S26–S30.

Satia I, Cusack R, Greene JM, O’Byrne PM, Killian KJ, Johnston N. Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma. PLoS One . 2020;15:e0228544.

Burney P, Patel J, Minelli C, Gnatiuc L, Amaral AFS, Kocabas A, et al.BOLD Collaborative Research Group Prevalence and population-attributable risk for chronic airflow obstruction in a large multinational study. Am J Respir Crit Care Med . 2021;203:1353–1365

Breyer-Kohansal R, Faner R, Breyer MK, Ofenheimer A, Schrott A, Studnicka M, et al. Factors associated with low lung function in different age bins in the general population. Am J Respir Crit Care Med . 2020;202:292–296.

Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, Montes de Oca M, Papi A, Sin DD, Han MK, Agusti A. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1317-1325. doi: 10.1164/rccm.202204-0671PP. PMID: 35914087; PMCID: PMC9746870.




DOI: https://doi.org/10.23857/pc.v8i7.5799

Enlaces de Referencia

  • Por el momento, no existen enlaces de referencia
';

Bookmark and Share




Polo del Conocimiento              

Revista Científico-Académica Multidisciplinaria

ISSN: 2550-682X

Casa Editora del Polo                                                 

Manta - Ecuador       

Dirección: Ciudadela El Palmar, II Etapa,  Manta - Manabí - Ecuador.

Código Postal: 130801

Teléfonos: 056051775/0991871420

Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com

URL: https://www.polodelconocimiento.com/